Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators

Frontiers in Immunology
Isabelle Le MercierRandolph J Noelle

Abstract

In the last two years, clinical trials with blocking antibodies to the negative checkpoint regulators CTLA-4 and PD-1 have rekindled the hope for cancer immunotherapy. Multiple negative checkpoint regulators protect the host against autoimmune reactions but also restrict the ability of T cells to effectively attack tumors. Releasing these brakes has emerged as an exciting strategy for cancer treatment. Conversely, these pathways can be manipulated to achieve durable tolerance for treatment of autoimmune diseases and transplantation. In the future, treatment may involve combination therapy to target multiple cell types and stages of the adaptive immune responses. In this review, we describe the current knowledge on the recently discovered negative checkpoint regulators, future targets for immunotherapy.

References

May 1, 1990·The Journal of Experimental Medicine·F TriebelT Hercend
May 23, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S El Mir, F Triebel
Apr 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Susanne AndreaeFrédéric Triebel
Nov 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Creg J WorkmanDario A A Vignali
Nov 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hirofumi AsakuraMitsuomi Hirashima
Jun 11, 2003·Nature Immunology·Norihiko WatanabeKenneth M Murphy
Apr 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Creg J WorkmanDario A A Vignali
May 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Peggy HanJonathan Kaye
Oct 16, 2004·Immunity·Ching-Tai HuangDario A A Vignali
Jan 7, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Creg J Workman, Dario A A Vignali
Jan 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Lino C GonzalezDan L Eaton
Feb 3, 2005·International Immunology·Jun ShirakawaAkira Shibuya
May 12, 2005·Immunology·Laëtitia Maçon-Lemaître, Frédéric Triebel
Jun 23, 2005·European Journal of Immunology·Malgorzata KisielowKlaus Karjalainen
Jul 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Valerie DardalhonVijay K Kuchroo
Aug 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shu-Yan DaiMitsuomi Hirashima
Nov 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Carsten KriegJonathan Kaye
Nov 16, 2005·Nature Immunology·Chen ZhuVijay K Kuchroo
Apr 26, 2006·International Immunology·Jun ShirakawaAkira Shibuya
May 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sylvia Frisancho-KissDeLisa Fairweather
Sep 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tsunekazu OikawaMiyuki Azuma
Jan 25, 2007·The EMBO Journal·Nianyu LiDario A A Vignali
May 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michelle A HurchlaKenneth M Murphy
May 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sylvia Frisancho-KissDelisa Fairweather
May 23, 2007·The Journal of Experimental Medicine·Jennifer KearleyClare M Lloyd
Oct 13, 2007·The Journal of Clinical Investigation·Joseph F GrossoCharles G Drake
Feb 20, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Masako SekiMitsuomi Hirashima
Apr 22, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bitao LiangRaphael Clynes
Jun 4, 2008·The Journal of Experimental Medicine·Marcos W SteinbergMitchell Kronenberg

❮ Previous
Next ❯

Citations

Jan 27, 2016·Proceedings of the National Academy of Sciences of the United States of America·Peggy P Ho, Lawrence Steinman
Jan 19, 2016·Annales de pathologie·Julien AdamSylvie Lantuéjoul
Mar 22, 2016·Journal of Immunology Research·Yelei GuoWeidong Han
Jun 2, 2016·Human Vaccines & Immunotherapeutics·Siqi ChenZhong Wang
Jan 26, 2016·The FEBS Journal·Gita ThanarajasingamStephen M Ansell
Aug 4, 2016·Endocrine-related Cancer·S LatteyerD Führer
Apr 29, 2016·BJU International·Jennifer M Mataraza, Philip Gotwals
Oct 6, 2016·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Anna C Belkina, Jennifer E Snyder-Cappione
Oct 25, 2016·The Journal of Investigative Dermatology·Neha JariwalaAlain H Rook
Oct 30, 2016·Trends in Immunology·Nicholas A ManieriJane L Grogan
Nov 12, 2016·Cancer Gene Therapy·W F MoranoW B Bowne
Aug 28, 2016·Annals of the Rheumatic Diseases·Leonard Calabrese, Vamsidhar Velcheti
Mar 1, 2017·Journal of Experimental & Clinical Cancer Research : CR·Yoshitaro ShindoHiroaki Nagano
Jan 12, 2017·Cell Communication and Signaling : CCS·Kemal CatakovicRoland Geisberger
Dec 30, 2016·Journal for Immunotherapy of Cancer·Jie DengRandolph J Noelle
Mar 16, 2018·Future Oncology·Amanda PrzespolewskiEunice S Wang
Mar 10, 2018·International Journal of Molecular Sciences·Divya SekarAndreas Weigert
Sep 8, 2017·American Journal of Physiology. Renal Physiology·Rahul Sharma, Gilbert R Kinsey
Dec 12, 2017·Frontiers in Immunology·Hai ZhaoYan Kang
Jan 10, 2018·Frontiers in Immunology·Hayana Ramos LimaAna Paula Campanelli
Jun 13, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anne MustersNiek de Vries
Jun 4, 2016·Journal of Leukocyte Biology·Anna E VilgelmAnn Richmond
Dec 5, 2018·Journal of Cellular Physiology·Sanam SadreddiniLeili Aghebati-Maleki
Nov 7, 2017·ESMO Open·Gilda VarricchiCarlo Gabriele Tocchetti
Jan 17, 2019·Journal of Cellular Physiology·Jin-Yu SunXiao-Jie Lu
Jan 15, 2019·Clinical and Experimental Immunology·A L Rodríguez-PereaP A Velilla-Hernández
Feb 15, 2019·Expert Opinion on Biological Therapy·Martyna FilipskaRafael Rosell
Mar 9, 2019·Journal of Leukocyte Biology·Mario Ernesto Cruz-MuñozJesus Santa-Olalla Tapia
Dec 23, 2015·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Yang Liu, Xuetao Cao
Jun 4, 2019·Current Opinion in Endocrinology, Diabetes, and Obesity·Peter S Linsley, S Alice Long
Sep 6, 2019·Scandinavian Journal of Immunology·Lizhen ZhaoBei Zhang
Oct 17, 2017·Oncotarget·Sabrina JutzPeter Steinberger
Dec 30, 2017·Oncotarget·Pawel KarpinskiMaria Malgorzata Sasiadek
May 5, 2017·Experimental Hematology & Oncology·Xiaolong ZhangDongsheng Xiong
May 5, 2018·Journal of Immunology Research·Jeffrey KouryAndrew Tran
Nov 18, 2018·Nature Immunology·Yuan Lui, Simon J Davis
Apr 26, 2019·Anti-cancer Drugs·Marcella OccelliMarco C Merlano
Jul 20, 2017·Journal of Leukocyte Biology·Jolien De MunckJoeri L Aerts

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Software Mentioned

TIGIT
VISTA

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

© 2021 Meta ULC. All rights reserved